NARA Discovery
Article Details
← Back to Search Results
Journal Article

A New Pathogen Population Challenges the Prevention and Control of Potato Late Blight in Denmark

Jens G. Hansen; Lars Bødker; Isaac K. Abuley
Potato Research · Vol. 69, Issue 1 · 2026

Abstract

Unexpected and severe outbreaks of potato late blight occurred in Denmark during the 2022 growing season due to the emergence and rapid spread of a new SSR genotype, EU43, which exhibited 100% resistance to mandipropamid. This prompted a shift in control recommendations from block applications of fungicides to fungicide mixing and alternation. Three early warning components played a critical role in the effective management of late blight in the 2023 season: (1) Disease surveillance using the BlightTracker app; (2) Blight risk forecasting via the BlightManager decision support system; and (3) An early sampling campaign followed by rapid reporting of genotyping and phenotyping results. In 2022, the EU43 genotype accounted for 64% of the Phytophthora infestans population. Following the new control strategy and intensified use of early warning tools, the frequency of the EU43 genotype declined to 19% in 2023 and 5% in 2024. Amongst samples collected from different field types between 2022 and 2024, EU43 prevalence was 40% in experimental plots and conventional fields, 11% in volunteer plants, and 3% in organic fields. These findings support the hypothesis that EU43’s success was driven by its reduced sensitivity to mandipropamid. With the frequency of EU43 now reduced to 5%, mandipropamid can be reintroduced as part of a fungicide mixture and alternation strategy.

Bibliographic Information

JournalPotato Research
PublisherSpringer
Publication Date2026-02-01
Publication Year2026
Volume69
Issue1
Document TypeJournal Article
Print ISSN0014-3065
eISSN1871-4528
DOI10.1007/s11540-025-09986-3

Access Information

NARA Access Coverage1958-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11540
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.